Alexander P Stark1, Greg D Sacks2, Matthew M Rochefort2, Timothy R Donahue1, Howard A Reber1, James S Tomlinson2, David W Dawson3, Guido Eibl1, O Joe Hines4. 1. Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. 2. Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA; Department of Surgery, Greater Los Angeles VA Healthcare System, Los Angeles, CA. 3. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. 4. Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. Electronic address: joehines@mednet.ucla.edu.
Abstract
BACKGROUND: Long-term survival (LTS) is uncommon for patients with pancreatic ductal adenocarcinoma (PDAC). We sought to identify factors that predict 10-year, LTS after resection of PDAC. METHODS: We identified all patients with PDAC who underwent resection at UCLA after 1990 and included all patients eligible for observed LTS (1/1/1990-12/31/2004). An independent pathologist reconfirmed the diagnosis of PDAC in patients with LTS. Logistic regression was used to predict LTS on the basis of patient and tumor characteristics. RESULTS: Of 173 included patients, 53% were male, median age at diagnosis was 66 years, and median survival was 23 months. The rate of observed LTS was 12.1% (n = 21). Age, sex, number of lymph nodes evaluated, margin status, lymphovascular invasion, and adjuvant chemotherapy and radiation were not associated with LTS. The following were associated with LTS on bivariate analysis: low AJCC stage (Ia, Ib, IIa) (P = .034), negative lymph node status (P = .034), low grade (well-, moderately-differentiated) (P = .001), and absence of perineural invasion (P = .019). Only low grade (odds ratio 7.17, P = .012) and absent perineural invasion (odds ratio 3.28, P = .036) were independently associated with increased odds of LTS. Our multivariate model demonstrated good discriminatory power for LTS, as indicated by a c-statistic of 0.7856. CONCLUSION: Absence of perineural invasion and low tumor grade were associated with greater likelihood of LTS. Understanding the tumor biology of LTS may provide critical insight into a disease that is typically marked by aggressive behavior and limited survival.
BACKGROUND: Long-term survival (LTS) is uncommon for patients with pancreatic ductal adenocarcinoma (PDAC). We sought to identify factors that predict 10-year, LTS after resection of PDAC. METHODS: We identified all patients with PDAC who underwent resection at UCLA after 1990 and included all patients eligible for observed LTS (1/1/1990-12/31/2004). An independent pathologist reconfirmed the diagnosis of PDAC in patients with LTS. Logistic regression was used to predict LTS on the basis of patient and tumor characteristics. RESULTS: Of 173 included patients, 53% were male, median age at diagnosis was 66 years, and median survival was 23 months. The rate of observed LTS was 12.1% (n = 21). Age, sex, number of lymph nodes evaluated, margin status, lymphovascular invasion, and adjuvant chemotherapy and radiation were not associated with LTS. The following were associated with LTS on bivariate analysis: low AJCC stage (Ia, Ib, IIa) (P = .034), negative lymph node status (P = .034), low grade (well-, moderately-differentiated) (P = .001), and absence of perineural invasion (P = .019). Only low grade (odds ratio 7.17, P = .012) and absent perineural invasion (odds ratio 3.28, P = .036) were independently associated with increased odds of LTS. Our multivariate model demonstrated good discriminatory power for LTS, as indicated by a c-statistic of 0.7856. CONCLUSION: Absence of perineural invasion and low tumor grade were associated with greater likelihood of LTS. Understanding the tumor biology of LTS may provide critical insight into a disease that is typically marked by aggressive behavior and limited survival.
Authors: Timothy R Donahue; William H Isacoff; O Joe Hines; James S Tomlinson; James J Farrell; Yasser M Bhat; Edward Garon; Barbara Clerkin; Howard A Reber Journal: Arch Surg Date: 2011-07
Authors: Werner Hartwig; Thilo Hackert; Ulf Hinz; Alexander Gluth; Frank Bergmann; Oliver Strobel; Markus W Büchler; Jens Werner Journal: Ann Surg Date: 2011-08 Impact factor: 12.969
Authors: Bettina M Rau; Katharina Moritz; Sarah Schuschan; Guido Alsfasser; Friedrich Prall; Ernst Klar Journal: Surgery Date: 2012-07-03 Impact factor: 3.982
Authors: Nabil Wasif; Clifford Y Ko; James Farrell; Zev Wainberg; Oscar J Hines; Howard Reber; James S Tomlinson Journal: Ann Surg Oncol Date: 2010-04-27 Impact factor: 5.344
Authors: Marianne Sinn; Jana K Striefler; Bruno V Sinn; Daniel Sallmon; Sven Bischoff; Jens M Stieler; Uwe Pelzer; Marcus Bahra; Peter Neuhaus; Bernd Dörken; Carsten Denkert; Hanno Riess; Helmut Oettle Journal: J Surg Oncol Date: 2013-08-23 Impact factor: 3.454
Authors: Matthew M Rochefort; Jacob S Ankeny; Brian E Kadera; Graham W Donald; William Isacoff; Zev A Wainberg; O Joe Hines; Timothy R Donahue; Howard A Reber; James S Tomlinson Journal: Ann Surg Oncol Date: 2013-08-14 Impact factor: 5.344
Authors: Ibrahim Halil Sahin; Mohamed A Shama; Motofumi Tanaka; James L Abbruzzese; Steven A Curley; Manal Hassan; Donghui Li Journal: Cancer Med Date: 2012-10-30 Impact factor: 4.452
Authors: Martin Graversen; Sönke Detlefsen; Jon Kroll Bjerregaard; Per Pfeiffer; Michael Bau Mortensen Journal: Clin Exp Metastasis Date: 2017-05-17 Impact factor: 5.150
Authors: Marc A Attiyeh; Jayasree Chakraborty; Alexandre Doussot; Liana Langdon-Embry; Shiana Mainarich; Mithat Gönen; Vinod P Balachandran; Michael I D'Angelica; Ronald P DeMatteo; William R Jarnagin; T Peter Kingham; Peter J Allen; Amber L Simpson; Richard K Do Journal: Ann Surg Oncol Date: 2018-01-29 Impact factor: 5.344
Authors: Nayra S Amaral; Vivian Resende; José Sebastião Dos Santos; Luiz Felipe Lima; Debora C Moraes; Eitan Friedman; Luiz DE Marco; Luciana Bastos-Rodrigues Journal: In Vivo Date: 2018 Nov-Dec Impact factor: 2.155
Authors: Derek J Erstad; Mozhdeh Sojoodi; Martin S Taylor; Veronica Clavijo Jordan; Kenneth K Tanabe; Peter Caravan; Bryan C Fuchs; Christian T Farrar; Andrea L Axtell; Nicholas J Rotile; Chloe Jones; Katherine A Graham-O'Regan; Diego S Ferreira; Theodoros Michelakos; Filippos Kontos; Akhil Chawla; Shen Li; Sarani Ghoshal; Yin-Ching Iris Chen; Gunisha Arora; Valerie Humblet; Vikram Deshpande; Motaz Qadan; Nabeel Bardeesy; Cristina R Ferrone; Michael Lanuti Journal: Clin Cancer Res Date: 2020-07-01 Impact factor: 12.531